CTIS2023-507744-36-00进行中（未招募）1 期
The effect of naldemedine on opioid-induced bowel dysfunction
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 年龄范围
- 18 至 64（—）
- 性别
- Male
入选标准
- •Healthy (assessed by a study-affiliated medical doctor), •Signed informed consent, •Able to read and understand Danish, •Male (to avoid influence of menstrual cycles), •Northern European descent (to minimize genetic variance influences on drug metabolism), •The researcher believes that the participant understands the study details, is compliant and is expected to complete the study, •Opioid naïve, •Between 20 and 40 years of age, •A STAI score in the range of 20-37 i.e., classified as no or low anxiety” at inclusion
排除标准
- •Known hypersensitivity or allergy towards the used pharmaceutical compounds or pharmaceutical compounds similar to those used in the study, •Daily alcohol consumption, •Participation motivated by wrongful” reasons such as poor economy or psychosocial issues e.g., problems in the family, loneliness, sadness. People with such problems may be more likely to develop substance dependence, •Intake of alcohol within 48 hours before start of study period or any alcohol consumption during each study period. If consumption takes place during the study the participant will be excluded, •Use of any analgesic medication within 48 hours before start as well as for the duration of the study, •Nicotine use, •Less than three spontaneous bowel movements per week, •Participation in other studies within 14 days prior to first visit, •Expected need of medical/surgical treatment during the study, •Any diagnosed disease, which investigator concludes will affect the trial (including all contraindicated complications: severe chronic obstructive pulmonary disease, pulmonary heart disease, severe bronchial asthma, paralytic ileus, hypercapnia, serious respiratory depression with hypoxia, moderate to severe decreased liver function, gastrointestinal obstruction or perforation, acute surgical abdominal complications such as appendicitis, Mb. Crohn’s, ulcerative colitis, and toxic mega colon), •History of substance abuse (alcohol, THC, benzodiazepine, central stimulants and/or opioids, urine drug test will be performed prior to treatment start), •History of major mental disorders (e.g., major anxiety, major depression or treatment with psychoactive medications etc.), •Metal implants or pacemaker, •Daily use of prescription only medicine
研究者
相似试验
招募中
2 期
The Effect of Naldemedine on Opioid-induced Bowel DysfunctionOpioid-Induced Bowel DysfunctionConstipationNCT06334198Asbjørn Mohr Drewes20
进行中（未招募）
2 期
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial of the Preventive Effect of Naldemedine on Opioid-Induced ConstipationeoplasmsCancer, Opioid induced constipationD009369JPRN-jRCTs031200397Jun Hamano100
招募中
Unknown
Observational study on opioid-induced constipation in patients with non-cancer chronic pain using weak opioid analgesics in JapaOpioid Induced ConstipationJPRN-UMIN000050203Shionogi & Co., Ltd.60
进行中（未招募）
1 期
Tramadol OIBDOpioid induced bowel dysfunctionCTIS2022-500108-23-00Aalborg University Hospital20
招募中
不适用
Effect of Intravenous lidocaine on opioid consumption in Video-Assisted Thoracoscopic Surgery-Nausea-vomitting-pain score-lidocaine toxicityintraveous lidocaineVideo-assisted thoracoscopic surgeryTCTR20181211001none40